HER2 Support Group Forums - View Single Post - new article by Genentech authors--herceptin TM1 works equivanlently2 herceptin AND

Lani · 09-13-2010, 08:41 AM

bumping this up as it is relevant and supports info Chrisy and others have provided to the thread on what can be done to let FDA know TDM-1 approval obstruction is harmful to the health of those her2+ breast cancer patients running out of options--it adds that both adjuvant and neoadjuvant trials are being designed and begun and the rationale for these

Seems the improved efficacy over herceptin (without changing its pharmacokinetics) and its ability to work when herceptin and/or tykerb no longer do not are truly motivating them to proceed despite this setback

09-13-2010, 08:41 AM	#2
Lani Senior Member Join Date: Mar 2006 Posts: 4,778	Re: new article by Genentech authors--herceptin TM1 works equivanlently2 herceptin bumping this up as it is relevant and supports info Chrisy and others have provided to the thread on what can be done to let FDA know TDM-1 approval obstruction is harmful to the health of those her2+ breast cancer patients running out of options--it adds that both adjuvant and neoadjuvant trials are being designed and begun and the rationale for these Seems the improved efficacy over herceptin (without changing its pharmacokinetics) and its ability to work when herceptin and/or tykerb no longer do not are truly motivating them to proceed despite this setback